Challenge
GMOs (Genetically Modified Organisms) have the potential to vastly improve our food supply with products that are more nutritious, productive, sustainable or transportable. But new GMOs are subject to intensive regulatory review before they can hit the grocery store aisles.
In order to prove that a GMO is safe, Agroscience developers need to be able to prove that the new plant does not produce unexpected proteins that could induce an allergic response in susceptible individuals. To test for allergenic potential, developers need to be able to answer several questions: what proteins or peptides are produced as a result of the inserted genetic sequence? Are they different than those produced in the non-GMO/parent form of the organism? And if so, do they match any proteins known to produce an allergic response in humans?
The Solution
The Outcome
Case Studies
Technology Commercialization and Licensing
With over 90 years of research and development experience, Battelle supports all areas of industry with intellectual property licensing focused on bringing our cross-disciplinary expertise to meet our clients' most difficult challenges.